<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39372632</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0971-4065</ISSN><JournalIssue CitedMedium="Print"><Volume>34</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Indian journal of nephrology</Title><ISOAbbreviation>Indian J Nephrol</ISOAbbreviation></Journal><ArticleTitle>A Prospective Study of Incidence, Risk Factors, and Outcomes of Acute Kidney Injury in Coronavirus Disease 2019.</ArticleTitle><Pagination><StartPage>461</StartPage><EndPage>466</EndPage><MedlinePgn>461-466</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.25259/ijn_399_23</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Acute kidney injury (AKI) is common after coronavirus 2 infection (COVID-19), leading to higher morbidity and mortality. There is little prospective data from India regarding the incidence, risk factors, and outcome of AKI in COVID-19.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">This study was conducted prospectively in adult patients between September and December 2020 in a tertiary care hospital in the national capital region of Delhi. A total of 856 patients with COVID-19 infection were enrolled in the study. Survivors were followed for 3 months after discharge.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Out of 856 patients, 207 (24%) developed AKI. AKI was significantly higher in those with severe disease as compared to mild-moderate disease (88% vs. 12%, <i>P</i> = 0.04). Out of all AKI, 3.4% had stage 1, 9.2% had stage 2, and the rest 87.4% had stage 3 AKI. 183/207 (88%) patients were on mechanical ventilators, 133 (64%) required inotropic support, and 137/207 (83.6%) patients required kidney replacement therapy. Out of 207 AKI patients, 74% (153) died as compared to 4% (27) in non-AKI group (<i>P</i> = 0.0001). After 3 months, chronic kidney disease (CKD) developed in 10/54 (18.5%) patients. On multivariable analysis, the presence of diabetes mellitus, severe COVID-19 disease, high levels of C reactive protein, lactate dehydrogenase, D-Dimer, and use of intravenous steroids, tocilizumab and remdesivir, were found to be significant predictors of AKI.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">AKI is common after COVID-19 infection and it is a significant risk factor for mortality in COVID-19. Patients with diabetes and high levels of inflammatory markers have higher mortality. CKD may develop in many patients after discharge.</AbstractText><CopyrightInformation>© 2024 Indian Journal of Nephrology | Published by Scientific Scholar.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bansal</LastName><ForeName>Shyam Bihari</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0002-8665-8588</Identifier><AffiliationInfo><Affiliation>Department of Nephrology and Kidney Transplantation, Medanta Kidney and Urology Institute, Medanta-The Medicity, Gurgaon, Haryana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babras</LastName><ForeName>Mayur</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Seth Nandlal, Dhoot Hospital, Aurangabad, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rana</LastName><ForeName>Abhyudaysingh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nephrology and Kidney Transplantation, Medanta Kidney and Urology Institute, Medanta-The Medicity, Gurgaon, Haryana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahapatra</LastName><ForeName>Amit</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7727-8831</Identifier><AffiliationInfo><Affiliation>Department of Nephrology and Kidney Transplantation, Medanta Kidney and Urology Institute, Medanta-The Medicity, Gurgaon, Haryana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yadav</LastName><ForeName>Dinesh Kumar</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Nephrology and Kidney Transplantation, Medanta Kidney and Urology Institute, Medanta-The Medicity, Gurgaon, Haryana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sethi</LastName><ForeName>Sidharth Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Nephrology and Kidney Transplantation, Medanta Kidney and Urology Institute, Medanta-The Medicity, Gurgaon, Haryana, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Nephrol</MedlineTA><NlmUniqueID>8914356</NlmUniqueID><ISSNLinking>0971-4065</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">India</Keyword><Keyword MajorTopicYN="N">Kidney replacement therapy</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>7</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39372632</ArticleId><ArticleId IdType="pmc">PMC11450852</ArticleId><ArticleId IdType="doi">10.25259/ijn_399_23</ArticleId><ArticleId IdType="pii">10.25259/ijn_399_23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation> WHONcCJ. Available from:  https://www.who.int/csr/don/12-january-2020-novelcoronavirus-aa,china/en [Last accessed on 2020 Apr 19]</Citation></Reference><Reference><Citation>Jain VK, Iyengar KP, Vaishya RJ. Differences between first wave and second wave of COVID-19 in India. Diabetes Metab Syndr. 2021;15:1047–8. doi: 10.1016/j.dsx.2021.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.05.009</ArticleId><ArticleId IdType="pmc">PMC8106236</ArticleId><ArticleId IdType="pubmed">33992554</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934–43. doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75:2352–71. doi: 10.1016/j.jacc.2020.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7198856</ArticleId><ArticleId IdType="pubmed">32201335</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarpioni R, Valsania T, Albertazzi V, Blanco V, DeAmicis S, Manini A, et al. Acute kidney injury, a common and severe complication in hospitalized patients during the COVID-19 pandemic. J Nephrol. 2021;34:1019–24. doi: 10.1007/s40620-021-01087-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-021-01087-x</ArticleId><ArticleId IdType="pmc">PMC8214067</ArticleId><ArticleId IdType="pubmed">34146335</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98:209–18. doi: 10.1016/j.kint.2020.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7229463</ArticleId><ArticleId IdType="pubmed">32416116</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, et al. A systematic review and meta-analysis of outcomes for patients with COVID-19 and acute kidney injury. Kidney Int Rep. 2020;5:1149–60. doi: 10.1016/j.ekir.2020.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2020.06.013</ArticleId><ArticleId IdType="pmc">PMC7314696</ArticleId><ArticleId IdType="pubmed">32775814</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829–38. doi: 10.1016/j.kint.2020.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.03.005</ArticleId><ArticleId IdType="pmc">PMC7110296</ArticleId><ArticleId IdType="pubmed">32247631</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO AKI Work Group KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;17:1–138.</Citation></Reference><Reference><Citation>Yang R, Li X, Liu H, Zhen Y, Zhang X, Xiong Q, et al. Chest CT severity score: An imaging tool for assessing severe COVID-19. Radiol Cardiothorac Imaging. 2020;2:e200047. doi: 10.1148/ryct.2020200047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/ryct.2020200047</ArticleId><ArticleId IdType="pmc">PMC7233443</ArticleId><ArticleId IdType="pubmed">33778560</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi S, Parkar J, Ansari A, Vora A, Talwar D, Tiwaskar M, et al. Role of favipiravir in the treatment of COVID-19. Int J Infect Dis. 2021;102:501–8. doi: 10.1016/j.ijid.2020.10.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.069</ArticleId><ArticleId IdType="pmc">PMC7831863</ArticleId><ArticleId IdType="pubmed">33130203</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman JD, Lye DC, Hui DS, Marks KM, Bruno R, Montejano R, et al. Remdesivir for 5 or 10 days in patients with severe Covid-19. N Engl J Med. 2020;383:1827–37. doi: 10.1056/NEJMoa2015301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015301</ArticleId><ArticleId IdType="pmc">PMC7377062</ArticleId><ArticleId IdType="pubmed">32459919</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693–704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadim MK, Forni LG, Mehta RL, Connor MJ, Liu KD, Ostermann M, et al. COVID-19-associated acute kidney injury: Consensus report of the 25th acute disease quality initiative (ADQI) workgroup. Nat Rev Nephrol. 2020;16:747–64. doi: 10.1038/s41581-020-00356-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-020-00356-5</ArticleId><ArticleId IdType="pmc">PMC7561246</ArticleId><ArticleId IdType="pubmed">33060844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S, et al. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol. 2021;32:151–60. doi: 10.1681/ASN.2020050615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020050615</ArticleId><ArticleId IdType="pmc">PMC7894657</ArticleId><ArticleId IdType="pubmed">32883700</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Xu D, Fu S, Zhang J, Yang X, Xu L, et al. Patients with COVID-19 in 19 ICUs in Wuhan, China: A Cross-sectional Study. Crit Care. 2020;24:219. doi: 10.1186/s13054-020-02939-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02939-x</ArticleId><ArticleId IdType="pmc">PMC7223395</ArticleId><ArticleId IdType="pubmed">32410714</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumlertgul N, Pirondini L, Cooney E, Kok W, Gregson J, Camporota L, et al. Acute kidney injury prevalence, progression and long-term outcomes in critically Ill patients with COVID-19: A cohort study. Ann Intensive Care. 2021;11:123. doi: 10.1186/s13613-021-00914-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00914-5</ArticleId><ArticleId IdType="pmc">PMC8343342</ArticleId><ArticleId IdType="pubmed">34357478</ArticleId></ArticleIdList></Reference><Reference><Citation>Darif D, Hammi I, Kihel A, Saik IE, Guessous F, Akarid KJ. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? Microb Pathog. 2021;153:104799. doi: 10.1016/j.micpath.2021.104799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.104799</ArticleId><ArticleId IdType="pmc">PMC7889464</ArticleId><ArticleId IdType="pubmed">33609650</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiswarya D, Arumugam V, Dineshkumar T, Gopalakrishnan N, Lamech TM, Nithya G, et al. Use of remdesivir in patients with covid-19 on hemodialysis: A study of safety and tolerance. Kidney Int Rep. 2021;6:586–93. doi: 10.1016/j.ekir.2020.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2020.12.003</ArticleId><ArticleId IdType="pmc">PMC7746511</ArticleId><ArticleId IdType="pubmed">33354635</ArticleId></ArticleIdList></Reference><Reference><Citation>Veiga VC, Prats JA, Farias DL, Rosa RG, Dourado LK, Zampieri FG, et al. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: Randomised controlled trial. BMJ. 2021;372:n84. doi: 10.1136/bmj.n84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n84</ArticleId><ArticleId IdType="pmc">PMC7815251</ArticleId><ArticleId IdType="pubmed">33472855</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Ran L, Qian C, Hua J, Luo Z, Ding M, et al. Epidemiology and outcomes of acute kidney injury in COVID-19 patients with acute respiratory distress syndrome: A multicenter retrospective study. Blood Purif. 2021;50:499–505. doi: 10.1159/000512371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512371</ArticleId><ArticleId IdType="pmc">PMC7801962</ArticleId><ArticleId IdType="pubmed">33291098</ArticleId></ArticleIdList></Reference><Reference><Citation>Arikan H, Ozturk S, Tokgoz B, Dursun B, Seyahi N, Trabulus S, et al. Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the turkish society of nephrology. PLoS One. 2021;16:e0256023. doi: 10.1371/journal.pone.0256023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0256023</ArticleId><ArticleId IdType="pmc">PMC8354466</ArticleId><ArticleId IdType="pubmed">34375366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng JH, Hirsch JS, Hazzan A, Wanchoo R, Shah HH, Malieckal DA, et al. Outcomes among patients hospitalized with COVID-19 and acute kidney injury. Am J Kidney Dis. 2021;77:204–15.e1. doi: 10.1053/j.ajkd.2020.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2020.09.002</ArticleId><ArticleId IdType="pmc">PMC7833189</ArticleId><ArticleId IdType="pubmed">32961245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>